Publication:
An open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

No Thumbnail Available

Date

2015-06-01

Authors

Dane, F.
Özgürdal, K.
Yalçın, S.
Benekli, M.
Aykan, N. F.
Yücel, I.
Özkan, M.
Evrensel, T.
Sevinç, A.
Coşkun, H. S.

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press

Research Projects

Organizational Units

Journal Issue

Abstract

Bu çalışma, 1-4 Temmuz 2015 tarihlerinde Barcelona'da düzenlenen ESMO 17. Dünya Gastrointestinal Kanser Kongresinde bildiri olarak sunulmuştur.

Description

Keywords

Science & technology, Life sciences & biomedicine, Oncology, Oncology

Citation

Collections

3

Views

0

Downloads

Search on Google Scholar